Unilabs Reports First Quarter 2015 Financial Results
Geneva, 18 May 2015: Unilabs, one of the leading players in the €70bn a year European medical diagnostic market1 announced today that for the quarter ending 31 March 2015, reported revenue was €167.6m, compared to €155.2m in Q1 2014.  The results show a significant and positive organic sales growth of 5.5% (CER†) leading to EBITDA growth vs last year of 12.2%.

More news on the News and Media Section
Unilabs is proud to participate in the Beaune Private Health Cluster project
On the 9th of April, Unilabs, along with Group of private practitioners and companies, participated in laying the first stone for the Beaune private Health Cluster.

Of all Private Health Clusters of the Dijon area, the Beaune project is the only one to be 100% privately funded.

Our Partnerships, Expertise & Network

We are a partner of choice and leading provider of outsourced diagnostic services with more than 200 diagnostic contracts across Europe.
Our services include: laboratory medicine, medical imaging, histopathology, reproductive medicine, and drug development services.
With operations in 11 countries, we are positioned as a regional leader with one of the broadest geographic coverage in Europe.